Potential histological discordance revealed by second review in the national rare gynecological cancer network (TMRG).
Fiche publication
Date publication
avril 2022
Journal
Gynecologic oncology
Auteurs
Membres identifiés du Cancéropôle Est :
Dr ARNOULD Laurent, Dr AVEROUS Gerlinde, Dr LEROUX Agnès
Tous les auteurs :
Henno S, Jeanne C, Rouge TM, Genestie C, Treilleux I, Croce S, Just PA, Le Frere-Belda MA, Guinaudeau E, Penault-Llorca F, Arnould L, Mery-Lamarche E, Leroux A, Lemaire AS, Averous G, Renaud O, Charafe-Jauffret E, Bonneau C, Leaha C, Ray-Coquard I, Devouassoux-Shisheboran M
Lien Pubmed
Résumé
Since 2010, the network of rare malignant tumors of the ovary (TMRG) was developed to optimize the management of patients, also allowing a histological second opinion of rare ovarian tumors. The aim of this work was to study the contribution of second opinion to improve histological diagnostic accuracy on ovarian rare malignant tumors included in the TMRG database.
Mots clés
Concordance evaluation, Network, Ovarian tumor, Pathological discordance, Pathological review, Rare ovarian tumor
Référence
Gynecol Oncol. 2022 Apr 4;: